Nicolas PENEL

Has grant

Professor of Medical Oncolgy

Université de Lille

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Phase II – Multicentric, randomized, stratified, double-blind phase III study comparing weekly paclitaxel versus weekly paclitaxel plus bevacizumab in patients with unresectable or metastatic angiosarcoma (Angio-Tax-Plus study)

Open Date: 2010-06-01

Close Date: 2013-06-01

Grant: Close

A multicenter randomized phase II study to evaluate the benefit of chemotherapy plus best supportive care (BSC) versus BSC in patients with metastatic oesophageal cancer (MOEC) of squamous-cell type (SC) (MOEC-SC) who have not experienced disease progression or unacceptable toxicity during a 2 month-course of chemotherapy

Open Date: 2010-06-01

Close Date: 2013-06-01

Grant: Close

Phase II randomised trial to evaluate two strategies: continuing versus intermittent (drug-holiday) trabectedin-regimen in patients with advanced soft tissue sarcoma experiencing response or stable disease after the sixth cycle.

Open Date: 2008-02-08

Close Date: 2011-02-08

Grant: Close

2007: O-MEL-INIB- « Multicentric phase II of imatinib mesylate in patients with metastatic uveal melanoma »

Open Date: 2007-06-01

Close Date: 2010-06-01

Grant: Close

2007: AngioNext- « Multicentric stratified phase II study of sorafenib in patients with metastatic or unresectable angiosarcoma»

Open Date: 2007-06-01

Close Date: 2010-06-01

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Anthony Turpin

FRANCE

View details

Loïc Lebellec

Université Lille 2 Droit et Santé

FRANCE

View details

Camille Tlemsani

Université Paris Cité

FRANCE

View details

Jean-Jacques Lemaire

Université Clermont Auvergne

FRANCE

View details

Peter Grimison

The University of Sydney School of Medicine

AUSTRALIA

View details

Jae Lyun Lee

University of Ulsan College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicolas PENEL

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (16)

L’oncologie : lieu de stage hospitalier idéal pour la R2C ?

Why do second-cycle medical students choose oncology? A literature overview

Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study

Doit-on prendre en compte le stress informationnel de l’oncologue médical ?

Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF)

Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study

Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value

Why will there never be a randomized trial for NTRK-rearranged tumors?

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer

Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study

A lesion suspected of being a desmoid tumor in the context of familial adenomatous polyposis should be biopsied

Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours

Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study

Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis

Collaborators (6)

Anthony Turpin

Loïc Lebellec

Camille Tlemsani

Jean-Jacques Lemaire

Peter Grimison

Jae Lyun Lee

Make your next move.